Esomeprazole Export Market Intelligence: India's 643 Suppliers Shipping to 147 Countries — TransData Nexus 2026

Q: Who are the top esomeprazole exporters from India?

The top esomeprazole exporters from India are: 1. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $198.0M (43.4% market share); 2. CIPLA LIMITED — $69.2M (15.1% market share); 3. MYLAN LABORATORIES LIMITED — $35.3M (7.7% market share); 4. MICRO LABS LIMITED — $30.6M (6.7% market share); 5. DR.REDDY'S LABORATORIES LTD — $18.7M (4.1% market share). Together they account for 77.1% of India's total esomeprazole export value.

Q: What is the total export value of esomeprazole from India?

The total export value of esomeprazole from India is $456.5M USD, recorded across 9,532 shipment transactions from 643 active exporters to 147 destination countries. The average shipment value is $47.9K.

Q: Which countries import esomeprazole from India?

India exports esomeprazole to 147 countries worldwide. The top importing countries are: UNITED STATES (24.4% share, $111.5M), CANADA (19.6% share, $89.6M), BELGIUM (16.4% share, $74.8M), VIETNAM (6.5% share, $29.6M), AUSTRALIA (6.5% share, $29.5M). These five markets account for 73.4% of total export value.

Q: What is the HS code for esomeprazole exports from India?

The primary HS code for esomeprazole exports from India is 30049039. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of esomeprazole exports from India?

The average unit price for esomeprazole exports from India is $4.31 USD per unit, with prices ranging from $0.00 to $1467.29 depending on formulation, packaging, and order volume. The total market is valued at $456.5M across 9,532 shipments.

Q: Which ports handle esomeprazole exports from India?

The primary ports for esomeprazole exports from India are NHAVA SHEVA SEA (INNSA1) (8.7% of shipments), SAHAR AIR (8.6% of shipments), SAHAR AIR CARGO ACC (INBOM4) (7.4% of shipments), DELHI AIR CARGO ACC (INDEL4) (6.6% of shipments), DELHI AIR (5.5% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of esomeprazole?

India is one of the world's leading exporters of esomeprazole due to its large base of 643 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports esomeprazole to 147 countries, demonstrating 75% global market coverage.

Q: What certifications do Indian esomeprazole exporters need?

Indian esomeprazole exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import esomeprazole from India?

There are 1,634 registered buyers importing esomeprazole from India, spread across 147 countries. The repeat buyer rate is 62.5%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top esomeprazole supplier from India?

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the leading esomeprazole exporter from India with a market share of 43.4% and total export value of $198.0M across 1649 shipments. The top 5 suppliers together control 77.1% of total export value.

Suresh Sormare

Esomeprazole

India Pharmaceutical Trade Intelligence

$456.5M643 Suppliers147 CountriesHS 30049039

ExportsIndia → UNITED STATES24.4%India → CANADA19.6%

ImportsSPAIN → India$457.1K GERMANY → India$43.1K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: YUSEN LOGISTICS

Esomeprazole Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Esomeprazole to the World

Between 2022 and 2026, India exported $456.5M worth of esomeprazole across 9,532 verified shipments to 147 countries — covering 75% of world markets in the Gastrointestinal segment. The largest destination is UNITED STATES (24.4%). SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with a 43.4% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published May 2026·Updated May 2026·

Esomeprazole export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Esomeprazole export data snapshot — $456.5M · 643 exporters · 147 countriesTransData Nexus · Indian Customs Data

Top Esomeprazole Exporters from India

643 active exporters · Ranked by export value

View all 643 →

Top Esomeprazole Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$198.0M	1,649	19	43.4%
2	CIPLA LIMITED

Top Countries Importing Esomeprazole from India

147 destination markets · Ranked by import value

All 147 countries →

Top Countries Importing Esomeprazole from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$111.5M	24.4%
2	CANADA	$89.6M	19.6%
3	BELGIUM	$74.8M	16.4%
4	VIETNAM	$29.6M	6.5%
5	AUSTRALIA	$29.5M	6.5%
6	BRAZIL	$22.1M	4.8%
7	KENYA	$12.3M	2.7%
8	CHILE	$11.6M	2.5%
9	SOUTH AFRICA	$10.8M	2.4%
10	MEXICO	$5.7M	1.2%

UNITED STATES is India's largest esomeprazole export destination, absorbing 24.4% of total exports worth $111.5M. The top 5 importing countries — UNITED STATES, CANADA, BELGIUM, VIETNAM, AUSTRALIA — together account for 73.4% of India's total esomeprazole export value. The remaining 142 destination countries collectively receive the other 26.6%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Esomeprazole to India?

22 origin countries · Total import value: $1.0M

India imports esomeprazole from 22 countries with a combined import value of $1.0M. The largest supplier is SPAIN ($457.1K, 40 shipments), followed by UNITED STATES and GERMANY. All values are from Indian Customs (DGFT) import records.

Countries Supplying Esomeprazole to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	SPAIN	$457.1K	40	44.4%
2	UNITED STATES	$365.0K	144	35.5%
3	GERMANY	$43.1K	18	4.2%
4	UNITED KINGDOM	$42.3K	18	4.1%
5	CANADA	$35.8K	37	3.5%
6	BULGARIA	$24.3K	25	2.4%
7	NETHERLANDS	$21.3K	10	2.1%
8	AUSTRALIA	$11.3K	10	1.1%
9	SOUTH KOREA	$8.7K	4	0.8%
10	SWEDEN	$8.7K	7	0.8%

Showing top 10 of 22 origin countries

SPAIN is the largest supplier of esomeprazole to India, accounting for 44.4% of total import value. The top 5 origin countries — SPAIN, UNITED STATES, GERMANY, UNITED KINGDOM, CANADA — together supply 91.7% of India's esomeprazole imports. Click any country to see detailed supplier and buyer data for that import corridor.

Esomeprazole — Export Intelligence Video

Visual overview of India's esomeprazole import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's esomeprazole pharmaceutical import and export market — $456.5M in total trade, 643 verified manufacturers, and 147 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Esomeprazole

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Esomeprazole, a proton pump inhibitor, has been widely approved in the United States through Abbreviated New Drug Applications (ANDAs). The FDA's Orange Book lists multiple approved ANDAs for esomeprazole formulations, indicating a competitive generic market. Notably, in December 2025, the FDA approved ANDA 217714 for Esomeprazole Magnesium for Delayed-Release Oral Suspension, 2.5 mg and 5 mg, submitted by Cipla USA Inc., a subsidiary of India's Cipla Limited.

The regulatory pathway for esomeprazole involves demonstrating bioequivalence to the reference listed drug (RLD) and compliance with FDA's Current Good Manufacturing Practice (CGMP) regulations. Given the presence of 643 active Indian exporters and 1,634 buyers, with a repeat buyer rate of 62.5%, the US market remains a significant destination for Indian esomeprazole exports.

2EU & UK Regulatory Framework

In the European Union, esomeprazole is marketed under various brand names, including Nexium Control, which received marketing authorization from the European Medicines Agency (EMA) on August 26, 2013. (ema.europa.eu) The UK's Medicines and Healthcare products Regulatory Agency (MHRA) aligns with EMA standards, requiring marketing authorization and adherence to EU Good Manufacturing Practice (GMP) guidelines. These regulations ensure that esomeprazole products meet stringent quality, safety, and efficacy standards before reaching consumers.

3WHO Essential Medicines & Global Standards

Esomeprazole is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in treating acid-related disorders. The drug is also subject to international pharmacopoeia standards, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality across different markets.

4India Regulatory Classification

In India, esomeprazole is classified under Schedule H of the Drugs and Cosmetics Act, requiring a prescription for dispensing. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, esomeprazole is not listed under the Drug Price Control Order (DPCO), allowing market-driven pricing. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) to ensure compliance with international standards and regulations.

5Patent & Exclusivity Status

The primary patents for esomeprazole have expired, leading to a robust generic market with multiple manufacturers. This expiration has facilitated increased competition, resulting in more affordable options for consumers globally.

6Recent Industry Developments

In October 2025, the FDA approved a new generic formulation of esomeprazole magnesium delayed-release capsules, enhancing treatment options for gastroesophageal reflux disease (GERD).

In November 2025, the EMA's Committee for Medicinal Products for Human Use (CHMP) recommended updates to the product information for esomeprazole-containing medicines, emphasizing the importance of monitoring magnesium levels during prolonged use. (ema.europa.eu)

In December 2025, the NPPA conducted a review of proton pump inhibitors, including esomeprazole, to assess market prices and ensure affordability for patients.

In January 2026, the WHO updated its Essential Medicines List, reaffirming the inclusion of esomeprazole for the treatment of acid-related disorders.

In February 2026, the CDSCO issued new guidelines for the export of pharmaceutical products, including esomeprazole, to streamline the NOC process and facilitate international trade.

These developments reflect ongoing efforts by regulatory authorities to ensure the safety, efficacy, and affordability of esomeprazole in both domestic and international markets.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Esomeprazole

Retail & reference prices across 9 markets vs. India FOB export price of $4.31/unit

Global Price Benchmark for Esomeprazole across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.50	USD	According to the FDA's Orange Book, generic versions of esomeprazole have been approved, leading to competitive pricing in the market.
United Kingdom	$0.40	GBP	The NHS Drug Tariff lists esomeprazole, with prices subject to periodic review by the Department of Health and Social Care.
Germany	$0.38	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) regulates pharmaceutical pricing, ensuring affordability and availability.
Australia

Supply Chain Risk Assessment — Esomeprazole

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry heavily relies on China for Key Starting Materials (KSMs) essential in Active Pharmaceutical Ingredient (API) production. Approximately 60–70% of KSMs used in Indian APIs are imported from China. This dependency poses a significant risk, as any disruption in Chinese supply chains can directly impact India's API manufacturing capabilities. For instance, in June 2025, environmental regulations led to the shutdown of several Chinese chemical plants, causing a ripple effect that increased KSM prices and strained Indian API production.

To mitigate such risks, India has initiated the Production Linked Incentive (PLI) scheme, aiming to bolster domestic production of critical KSMs and APIs. In October 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules like Penicillin G and Clavulanic Acid, marking a significant step toward reducing import dependence.

2Supplier Concentration & Single-Source Risk

The esomeprazole export market is notably concentrated, with the top five exporters accounting for 77.1% of total exports. Sun Pharmaceutical Industries Limited alone holds a 43.4% share. Such concentration increases the risk of supply disruptions, as issues affecting these key players—be it regulatory challenges, quality control problems, or operational setbacks—can significantly impact global supply. For example, in February 2025, the FDA issued warning letters to API manufacturers in India and China for significant deviations from current Good Manufacturing Practices (cGMP), highlighting ongoing quality concerns.

Access Complete Esomeprazole Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 9,532 transactions across 147 markets.

Request Demo View Pricing

Frequently Asked Questions — Esomeprazole Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top esomeprazole exporters from India?

The leading esomeprazole exporters from India are SUN PHARMACEUTICAL INDUSTRIES LIMITED, CIPLA LIMITED, MYLAN LABORATORIES LIMITED, and 12 others. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with 43.4% market share ($198.0M). The top 5 suppliers together control 77.1% of total export value.

What is the total export value of esomeprazole from India?

The total export value of esomeprazole from India is $456.5M, recorded across 9,532 shipments from 643 active exporters to 147 countries. The average shipment value is $47.9K.

Which countries import esomeprazole from India?

India exports esomeprazole to 147 countries. The top importing countries are UNITED STATES (24.4%), CANADA (19.6%), BELGIUM (16.4%), VIETNAM (6.5%), AUSTRALIA (6.5%), which together account for 73.4% of total export value.

What is the HS code for esomeprazole exports from India?

The primary HS code for esomeprazole exports from India is 30049039. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Esomeprazole

Esomeprazole

Top Esomeprazole Exporters from India

Top Countries Importing Esomeprazole from India

Who Supplies Esomeprazole to India?

Quick Facts

Related Gastrointestinal

Related Analysis

Need Details?

Esomeprazole — Export Intelligence Video

Regulatory Landscape — Esomeprazole

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Esomeprazole

Supply Chain Risk Assessment — Esomeprazole

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Esomeprazole Trade Intelligence

Frequently Asked Questions — Esomeprazole Exports from India

Who are the top esomeprazole exporters from India?

What is the total export value of esomeprazole from India?

Which countries import esomeprazole from India?

What is the HS code for esomeprazole exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of esomeprazole exports from India?

Which ports handle esomeprazole exports from India?

Why is India a leading exporter of esomeprazole?

What certifications do Indian esomeprazole exporters need?

How many buyers import esomeprazole from India?

What is the market share of the top esomeprazole exporter from India?

Analysis Methodology